Diabetic nephropathy
Conditions
Interventions
telmisartan group (T group) :patients in the telmisartan group (T group) were given oral telmisartan at a dose of 40 mg daily for 4 weeks
Salvia miltiorrhiza injection + telmisartan (S + T group):patients in the Salvia miltiorrhiza injection + telmisartan (S + T group) were administered with Salvia miltiorrhiza injection combined with t
Sponsors
The Third Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
36 Years to 72 Years
Inclusion criteria
Inclusion criteria: (1) patients with clear history of diabetes; (2) urinary albumin excretion rate > 20 g/min (30 mg/L), or positive urinary protein or 24 hour urine quantitative protein > 0.5 g determined by conventional detection method; (3) patients with mild renal function (serum creatinine < 265 umol/L); (4) patients who met the above diagnosis criteria; (5) patients aged from 18 to 70 years old.
Exclusion criteria
Exclusion criteria: (1) patients who were clinically confirmed with nephritis, urinary tract infection, renal vascular disease and urinary tract obstruction diseases that could cause proteinuria; (2) pregnant or lactating women; (3) patients who had grievously heart, liver, renal dysfunction; (4) patients with thyroid disease, Cushing disease and other diseases of the endocrine system; (5) patients of allergic constitution or allergic to the present medicine; (6) psychiatric patients and who were unable to cooperate properly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Collagen IV;Fibronectin; | — |
Countries
China
Contacts
Public ContactNie Jieming
The Third Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed